GlassScriptPhysician profile
Carrie J Heuck
NPI 1457466757
$1,216.85
in general payments reported to CMS, 2019-2025
21 companies · $18.87 in 2025
The $18.87 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $88.58 · 2023: $765 · 2024: $345 · 2025: $18.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,128.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $248.29 | 2022-2024 | Mounjaro, Trulicity, Zepbound |
| Novo Nordisk INC | $201.27 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Insulet Corporation | $126.91 | 2022-2024 | Omnipod |
| Xeris Pharmaceuticals, INC. | $122.92 | 2023-2024 | Recorlev, Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $70.54 | 2022-2024 | |
| Amneal Pharmaceuticals LLC | $49.31 | 2023 | Unithroid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.26 | 2023-2024 | Jardiance |
| Corcept Therapeutics | $38.23 | 2023-2024 | Korlym |
| Cequr Corporation | $36.74 | 2023-2024 | Cequr Simplicity |
| Dexcom, INC. | $33.52 | 2023 | Dexcom G6 Transmitter |
| Tandem Diabetes Care, INC. | $31.94 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $31.88 | 2023 | Prolia, Evenity |
| Astrazeneca Pharmaceuticals LP | $29.02 | 2023 | Farxiga |
| Averitas Pharma INC. | $22.73 | 2023 | Qutenza |
| Abbott Laboratories | $21.47 | 2023 | Freestyle Libre 3 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $19.84 | 2024 | Mycapssa |
| Exact Sciences Corporation | $18.87 | 2025 | The Cologuard Plus Collection Kit |
| Medtronic, INC. | $17.40 | 2023 | Intellis Adaptivestim |
| Antares Pharma, INC. | $17.38 | 2023 | Xyosted, Tlando, Nocdurna |
| Ultragenyx Pharmaceutical INC. | $15.49 | 2024 | Crysvita |
| Sanofi-Aventis U.S. LLC | $14.84 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Heuck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.